Difference between revisions of "Combined Nuclear Medicine Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| + | *[[Media:10 23 2015 QIBA Nuclear Medicine Leadership Call Summary-FINAL.pdf|10.23.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | *[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:06 26 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|06.26.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:06 26 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|06.26.2015 QIBA Nuclear Medicine BCs Call Summary]] | ||
*[[Media:05 15 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|05.15.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:05 15 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT.pdf|05.15.2015 QIBA Nuclear Medicine BCs Call Summary]] | ||
*[[Media:04 10 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT-h.pdf|04.10.2015 QIBA Nuclear Medicine BCs Call Summary]] | *[[Media:04 10 2015 QIBA Nuclear Medicine BCs Call Summary-DRAFT-h.pdf|04.10.2015 QIBA Nuclear Medicine BCs Call Summary]] | ||